Geron Corporation, who we mentioned in a previous article, has just received a payment of $1.5 million from Exeter Life Sciences, Inc as part of a joint effort between the companies to continue further stem cell research. Geron is expected to be the first US company to complete human stem cell trials for the treatment of spinal cord injury.